Basic Science HY Flashcards
Bone
Growth Plate: What is the major source of nutrition to the growth plate?
After fracture, what is the blood flow immediate, hours to days?
IMN effect on blood flow?
What are the 3 sources of blood supply to bone?
Which way is arterial flow?
Blood supply to the growth plate is supplied both via the perichondrial artery, which is the main source of nutrients, and the epiphyseal artery, which supplies the proliferative zone of the growth plate
Bone
compressive strength from?
tensile strenth from?
- Compressive strength from proteoglycans & calcium hydroxyapatite (Ca10(PO4)6(OH)2)
- tensile strength from type I collagen
Bone metabolism: Calcium and Phosphate
% stored in bone, dietary intake?
Calcium: 99% in bone, hydroxyapatite, absorption in GI, resorption in Kidneys, Bone. Intake= adults 750 mg/day for adults; postmenopausal/fractures = 1500 mg/day for adults
Phosphate: 86% in bone, majority is hydroxyapatite, dietary intake= 1000-1500 mg/day
Bone Metabolism: PTH
increases/decrease?
synthesized in?
effect on bone?
in kidney?
Bone Metabolism: calcitonin
synthesized in?
action on bone?
recombinant calcitonin used for?
parafollicles of the thyroid gland (C cells);
inhibits osteoclastic bone resorption by decreasing number and activity of osteoclasts,
Inc. serum Ca > secretion of calcitonin > inhibition of osteoclasts > dec. Ca (transiently).
Recombinant calcitonin used to treat Paget disease, osteoporosis, and hypercalcemia in malignancy.
VitD
active form?
effect on bone?
lab test?
goal of treatment?
Estrogen in bone metabolism
what is the effect on bone?
benefits and risks of therapeutic estrogen?
lab findings in therapeutic estrogen?
prevents bone loss by decreasing the frequency of bone resorption and remodeling.
Therapeutic estrogen: decreases bone loss if started w/in 5-10 years of menopause, gains in bone mass limited to 2-4% annually in first 2 years of treatment
Risks: increased heart disease, breast cancer, decreased hip fx, endometrial fx.
Lab findings: decrease in urinary pridoline, serum alkaline phosphatase.
Bone metabolism: thyroid hormone
effect on bone?
Bone metabolism: GH
how does it regulate growth in bone?
In Gigantism, what effect does increased GH have on bone?
Steroids on bone:
increase bone loss by?
how does Teriparatide work?
intermittent Teriparatide, a PTH analog, is an anabolic anti-osteoporosis drug. Intermittent PTH has anabolic actions
bisphosphonates, estrogen, estrogen receptor modulators, denosumab, and calcitonin, all of which downregulate osteoclastic activity and are antiresorptive
limb development
Limb development Limb buds are first seen at ? weeks of gestation
Sonic hedge-hog (SHH) gene regulates ?
Zone of polarizing activity (ZPA): controls ?
Apical ectodermal ridge (AER): controls ?
Wnt controls ?
Limb development Limb buds are first seen at 8 weeks of gestation
Sonic hedge-hog (SHH) gene regulates limb bud formation / development
Zone of polarizing activity (ZPA): controls AP axis (radioulnar axis, or thumb to small finger; great toe to small toe)
Apical ectodermal ridge (AER): controls longitudinal limb growth
Wnt controls dorsoventral axis
Limb buds develop at 4 weeks and are first able to be visualized by transvaginal ultrasound at 8 weeks. During embryologic development, the limb bud has several defined regions. Two important regions are the apical ectodermal ridge (AER) and the zone of polarizing activity (ZPA). The AER controls longitudinal growth. Abnormal developement or loss of the AER will lead to a truncated limb (exact deformity depends on when in development the AER was affected). The ZPA acts via the sonic hedgehog (SHH) pathway to control anterior-posterior and radio-ulnar growth.
Decreased sun exposure leads to decreased bone health via?
Ultraviolet light from the sun is needed for skin cells to transform 7-dehydrocholesterol into cholecalciferol (vitamin D3). Once in the cholecalciferol form, it will then go to the liver and get hydroxylated into 25-hydroxyvitamin D and then to the kidneys to become 1,25-dihydroxyvitamin D. Lack of sunlight does not influence the ability of the liver or kidneys to perform hydroxylation, but it does affect the ability of the skin to create cholecalciferol, which in turn means no 1,25-vitamin D. Lack of 1,25 vitamin D has a direct impact on the GI tract’s ability to absorb calcium because the GI tract is an end organ affected by active vitamin D. The absence of 1,25 vitamin D would lead to increased levels of PTH, not decreased production of PTH.
What is the mechanism of action of calcitonin?
Interferes with osteoclast maturation
* reduces serum calcium concentration by directly interfering with osteoclast maturation via receptors
By attenuating cartilage breakdown and stimulating cartilage formation via inhibitory pathways of matrix metalloproteinases, calcitonin also has a chondro-protective effect on articular cartilage. Calcitonin has no major effects on intestinal absorption of calcium, but may aid in small-bowel secretion of sodium, potassium, chloride, and water. Calcitonin also has no receptor effect on osteoblasts.
Phosphate
administration decreases urinary calcium excretion through which of the following actions?
Phosphate reduces urine calcium excretion through several extrarenal mechanisms
- it creates a complex with calcium in the intestine to decrease available calcium for absorption.
- An increase in phosphate will directly stimulate PTH secretion and can reduce ionized calcium, also enhancing PTH secretion. The increased PTH will enhance calcium resorption. Phosphate will complex with calcium in the intestine, decreasing the amount of calcium for absorption. It can also complex with calcium in the bone and soft tissues, decreasing the filtered load of calcium. Decreased phosphate will result in hypercalcuria. There appears to be a direct effect of phosphate to decreased calcium reabsorption in the distal nephron.
excessive cortisol effect on
calcium?
Excessive cortisol
decreases intestinal calcium absorption
increases calcium loss from the kidney,
inhibits bone matrix formation
causes secondary hyperparathyroidism